managing-enhanced-recovery-protocols

# Managing Enhanced Recovery Protocols

Implements ERAS pathway elements with compliance tracking across preop, intraop, and postop phases.

## Why This Skill Exists

Enhanced Recovery After Surgery (ERAS) protocols are evidence-based, multimodal perioperative care pathways that significantly reduce complications, length of stay, and healthcare costs. The ERAS Society has published guidelines for over 20 surgical specialties, and meta-analyses consistently demonstrate 30-50% reduction in complications and 1-2 day reduction in length of stay when compliance exceeds 70%. ACS Strong for Surgery and CMS bundled payment models increasingly incentivize ERAS adoption.

However, ERAS implementation fails when elements are applied inconsistently. Studies show the dose-response relationship is real: each 10% increase in ERAS compliance produces a measurable reduction in complications. Institutions that track compliance element-by-element and feed data back to care teams achieve sustained improvement. This skill provides the complete ERAS framework across all three phases with a structured compliance tracking system.

---

## Checkpoint A: Pre-Draft Intake (Mandatory)

1. What surgical procedure is planned? **Default: [VERIFY]**
2. Which ERAS Society guideline applies (colorectal, hepatobiliary, pancreatic, gastric, gynecologic, urologic, thoracic, other)? **Default: colorectal**
3. What is the patient's ASA class and relevant comorbidities? **Default: ASA II**
4. Does the patient have diabetes, and if so, what is the current A1c? **Default: no diabetes**
5. Is the patient a current smoker or active substance user? **Default: no**
6. What is the patient's nutritional status (BMI, albumin)? **Default: albumin ≥3.0, BMI 18.5-30**
7. Has the patient been counseled on the ERAS pathway expectations? **Default: not yet**
8. Is the patient on chronic opioids? **Default: no**

### Documents to Request

- Applicable ERAS Society guideline document
- Institutional ERAS order set
- Patient education materials for the specific ERAS pathway
- Preoperative assessment results (labs, imaging, nutritional screen)
- Anesthesia plan aligned with ERAS elements
- Prior ERAS compliance data for the surgical team (if available)

---

## Step 1: Preoperative ERAS Elements

Implement all preoperative elements with documentation:

| Element | Protocol | Evidence Grade |
|---|---|---|
| **Patient education** | Structured counseling on pathway expectations, discharge goals, pain management approach | Strong |
| **Nutritional optimization** | Screen all patients; oral nutritional supplements x14 days preop if malnourished (albumin <3.0) | Strong |
| **Smoking cessation** | ≥4 weeks before elective surgery; offer pharmacotherapy (varenicline, NRT) | Strong |
| **Alcohol cessation** | ≥4 weeks before elective surgery | Strong |
| **Prehabilitation** | Exercise program 2-4 weeks preop for high-risk patients (functional capacity <4 METs) | Moderate |
| **Anemia management** | Treat iron deficiency (IV iron if <4 weeks to surgery); target Hgb >12 g/dL | Strong |
| **Carbohydrate loading** | 800 mL clear carbohydrate drink evening before surgery; 400 mL 2-3 hours preop | Strong |
| **No prolonged fasting** | Clear liquids up to 2 hours before anesthesia; solids up to 6 hours | Strong |
| **No routine bowel prep** | Mechanical bowel prep NOT recommended as standard for colorectal (oral antibiotics with MBP may reduce SSI — use per institutional protocol) | Strong |
| **VTE risk assessment** | Caprini score calculated; prophylaxis plan documented | Strong |
| **Antibiotic prophylaxis plan** | Agent selected per SCIP guidelines; timing planned for 60 min pre-incision | Strong |

Document compliance for each element: YES (completed) / NO (omitted with reason) / N/A (not applicable).

---

## Step 2: Intraoperative ERAS Elements

| Element | Protocol | Evidence Grade |
|---|---|---|
| **Short-acting anesthetic agents** | Propofol, remifentanil, desflurane/sevoflurane preferred; avoid long-acting benzodiazepines | Strong |
| **Antibiotic administration** | Given within 60 min of incision; re-dose if case >4h or EBL >1500 mL | Strong |
| **Surgical approach** | Minimally invasive approach preferred when oncologically equivalent | Strong |
| **Goal-directed fluid therapy (GDFT)** | Use esophageal Doppler or arterial waveform analysis to guide IV fluids; avoid overhydration (target zero balance) | Strong |
| **Normothermia** | Active warming (forced air); maintain temp ≥36.0°C throughout | Strong |
| **Restrictive IV fluids** | Balanced crystalloid (LR preferred over NS); avoid >3L unless GDFT-directed | Strong |
| **Nasogastric tube** | Do NOT place routinely; if placed intraop, remove before extubation | Strong |
| **Peritoneal drainage** | Do NOT place drains routinely in colorectal surgery | Moderate |
| **Regional analgesia** | Thoracic epidural or TAP block as part of multimodal plan | Strong |
| **PONV prophylaxis** | Multimodal: dexamethasone 4-8 mg + ondansetron 4 mg; add scopolamine patch for high-risk patients | Strong |

Document each element's compliance intraoperatively. The anesthesia record and circulating nurse documentation should capture fluid volumes, temperature, antibiotic timing, and PONV prophylaxis.

---

## Step 3: Postoperative ERAS Elements (POD 0-1)

| Element | Protocol | Evidence Grade |
|---|---|---|
| **Early oral intake** | Clear liquids POD 0 (within 4h of surgery); regular diet POD 1 | Strong |
| **Early mobilization** | Out of bed POD 0 (minimum 2h); ambulate 4x/day starting POD 1 | Strong |
| **Multimodal analgesia** | Scheduled acetaminophen + NSAID; opioids PRN only; epidural or TAP block | Strong |
| **Opioid-sparing approach** | Target ≤40 mg OME/day by POD 2; no basal PCA rate | Strong |
| **Early Foley removal** | Remove urinary catheter POD 1 (or intraop if case <2h with low fluid volume) | Strong |
| **VTE prophylaxis** | LMWH or UFH per Caprini score; SCDs continuous until ambulatory | Strong |
| **No routine NGT** | If ileus develops, attempt conservative management (ambulation, chewing gum) before NGT | Strong |
| **Glycemic control** | Maintain glucose <180 mg/dL; insulin protocol for diabetics | Strong |
| **Chewing gum** | Offer sugar-free gum TID (stimulates GI motility, reduces ileus) | Moderate |
| **Discharge planning** | Begin discharge planning POD 0; set patient expectations for discharge criteria | Strong |

Track and document hourly ambulation minutes and oral intake volumes.

---

## Step 4: Discharge Criteria and Extended Recovery

### Standardized Discharge Criteria (all must be met)

- [ ] Tolerating regular diet without nausea/vomiting
- [ ] Pain controlled on oral medications (NRS ≤4, meeting functional goals)
- [ ] Ambulating independently at baseline level
- [ ] Afebrile (T <38.0°C) for ≥24 hours
- [ ] No clinical signs of surgical complication
- [ ] Bowel function returned (passing flatus or BM — for GI surgery)
- [ ] Drain output acceptable for removal or patient educated on home drain care
- [ ] VTE prophylaxis plan for post-discharge documented (if extended course indicated)
- [ ] Follow-up appointment scheduled
- [ ] Patient demonstrates understanding of discharge instructions

### Expected Length of Stay by ERAS Protocol

| Procedure | Traditional LOS | ERAS Target LOS |
|---|---|---|
| Laparoscopic colectomy | 5-7 days | 2-3 days |
| Open colectomy | 7-10 days | 4-5 days |
| Pancreaticoduodenectomy | 10-14 days | 7-8 days |
| Laparoscopic cholecystectomy | 1-2 days | Same-day or 1 day |
| Total hip/knee replacement | 3-4 days | 1-2 days |

---

## Step 5: Compliance Tracking and Quality Improvement

### Element-Level Compliance Dashboard

Track compliance for each ERAS element per patient and aggregate by surgeon/service:

```
Compliance Rate = (Elements Completed / Total Applicable Elements) x 100
```

**Target: ≥80% overall compliance; no single element below 60%**

### Monthly ERAS Report Structure

1. **Volume**: Number of patients on the ERAS pathway
2. **Compliance**: Overall rate and element-by-element breakdown
3. **Outcomes**:
   - Average length of stay vs. ERAS target
   - 30-day complication rate (Clavien-Dindo ≥ II)
   - 30-day readmission rate
   - ED visit rate within 30 days
   - Opioid consumption (average OME at discharge)
4. **Variance analysis**: Identify the lowest-compliance elements and root causes
5. **Action items**: Targeted interventions for low-compliance elements

Common compliance failures and interventions:

| Low-Compliance Element | Common Root Cause | Intervention |
|---|---|---|
| Carbohydrate loading | Patient not instructed; drink not available | Pre-admit clinic provides drink at pre-op visit |
| Early mobilization POD 0 | Night admission to floor; nurse staffing | PT consult entered at time of booking |
| Early Foley removal | Order not written; nurse concern about retention | Auto-remove order in EHR at POD 1 06:00 |
| Multimodal analgesia | Opioids ordered first instead of non-opioids | Default order set with non-opioids pre-checked |

---

## Checkpoint B: Post-Draft Alignment (Mandatory)

1. Has every applicable ERAS element been documented as completed, omitted (with reason), or N/A?
2. Is the overall compliance rate calculated and ≥80%?
3. Are the expected LOS targets set and communicated to the patient and care team?
4. Is the discharge criteria checklist being used to drive discharge decisions?
5. Are monthly ERAS compliance and outcomes reports being generated?

---

## Quality Audit

- [ ] Patient education on ERAS pathway documented preoperatively
- [ ] Nutritional screening completed; supplements initiated if indicated
- [ ] Carbohydrate loading administered per protocol
- [ ] Fasting limited to 2h clear liquids / 6h solids
- [ ] Antibiotic prophylaxis given within 60 min of incision
- [ ] Goal-directed fluid therapy used intraoperatively
- [ ] Normothermia maintained (≥36.0°C)
- [ ] Minimally invasive approach used (or reason for open documented)
- [ ] PONV prophylaxis administered (multimodal)
- [ ] Early oral intake initiated POD 0
- [ ] Early mobilization documented (time out of bed POD 0)
- [ ] Multimodal analgesia with opioid-sparing approach documented
- [ ] Foley catheter removed POD 1 (or reason for delay documented)
- [ ] Discharge criteria checklist used
- [ ] ERAS compliance rate calculated per patient

---

## Guidelines

1. ERAS is a pathway, not a menu — the benefit comes from high compliance across ALL elements, not cherry-picking individual components. Each element omitted reduces the cumulative benefit.
2. Carbohydrate loading and limited fasting are safe in non-diabetic patients without gastroparesis. For diabetics, modify the carbohydrate load volume and check glucose on arrival.
3. Goal-directed fluid therapy reduces complications compared to both liberal and overly restrictive fluid strategies — the target is euvolemia, not a specific volume.
4. Early oral intake on POD 0 is safe even after colorectal surgery — multiple RCTs and meta-analyses confirm this does not increase anastomotic leak rates.
5. The single strongest predictor of ERAS success at the institutional level is compliance tracking with feedback to the care team — without measurement, compliance degrades to <50% within 6 months.
6. Do not use ERAS target LOS as a discharge mandate — patients must meet all discharge criteria regardless of POD number.
7. Extended VTE prophylaxis (28 days of LMWH) is recommended for major abdominal/pelvic cancer surgery per ERAS and ASCO guidelines.
8. Engage the entire perioperative team (surgery, anesthesia, nursing, PT, pharmacy, nutrition) in ERAS education — compliance depends on every team member executing their elements.